# Celldex Therapeutics, Inc.: Form 8-K, filed Apr 8, 2014

- Company: [Celldex Therapeutics, Inc.](/companies/cldx.md) (CIK 744218)
- Form: 8-K
- Filed: 2014-04-08
- Accepted by EDGAR: Apr 8, 2014, 09:16 ET
- Period: 2014-04-07
- Accession: 0001104659-14-026295
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/744218/000110465914026295/a14-10147_18k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/744218/000110465914026295/

## Items reported

- Item 5.03: Amendment to articles or bylaws
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/744218/000110465914026295/a14-10147_18k.htm

Filed Apr 8, 2014.
Source: SEC EDGAR, the filing index for accession 0001104659-14-026295. Last ingested by Listed: Nov 5, 2026, 19:04 ET. No prices; not investment advice.
